By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Cannabis NewsCannabis News
  • Cannabis
  • CBD
  • Science
  • Culture & Arts
  • Cannabis Press Releases
  • More
    • About Maryjanes Post
    • Cannabis Advertising
    • Cannabis Partnerships
Reading: Cansativa Group Closes $15M Series B to Become the ‘Amazon’ of Cannabis for Europe
Share
Aa
Aa
Cannabis NewsCannabis News
Search
  • Topics
    • Business
    • Cannabis
    • Cannabis Tech
    • Culture & Arts
    • Industry Leaders
    • Cannabis Press Releases
  • Topics
    • Business
    • Cannabis
    • Cannabis Tech
    • Culture & Arts
    • Industry Leaders
    • Cannabis Press Releases
  • About Maryjanes Post
    • Ambassador
    • Cannabis Partnerships
Follow US
  • Ad Choices
  • RSS Terms of Service
© 2018 - 2022 MaryJanes Post Media. All Rights Reserved.
Cannabis News > World News > Cansativa Group Closes $15M Series B to Become the ‘Amazon’ of Cannabis for Europe
World News

Cansativa Group Closes $15M Series B to Become the ‘Amazon’ of Cannabis for Europe

MJP Editors
Last updated: 2022/02/17 at 12:00 AM
MJP Editors Published February 17, 2022
Share
SHARE

The largest medical cannabis distributor in Germany readies for expansion into the recreational market

FRANKFURT, Germany, Feb. 16, 2022 /PRNewswire/ – Cansativa Group announced today it has closed a $15M Series B investment. The funding round was led by Casa Verde with participation by Argonautic Ventures and Munich-based family office Alluti. This represents Casa Verde’s largest investment in Germany and in Europe to date. 


Benedikt Sons and Jakob Sons, Founder and Managing Director, Cansativa Group (CNW Group/Cansativa Group)

As one of Germany’s largest cannabis businesses, Cansativa is building the ‘Amazon’ of cannabis for Europe, offering its customers a B2B platform to manage every stage of the value chain from importing goods to distributing them to thousands of pharmacies across the country. 

Given its exclusive relationship with German regulator, the Federal Institute for Drugs and Medical Devices (BfArM), Cansativa is the only company permitted to distribute domestically-grown medical cannabis.

The company will use the funding to expand its medical cannabis product portfolio and build out its recreational platform ahead of legalization in Germany.

“This investment from Casa Verde, one of the industry’s preeminent cannabis venture firms, is a significant milestone for our company and sends a strong message to the European cannabis market,” says Benedikt Sons, Founder, Managing Director and CEO of Cansativa Group. “It will allow us to realize our ambitious vision to become the operating backbone for cannabis retail in Germany and to play a vital role in enabling simple and safe access to cannabis for everyone.”

“Cansativa is strategically positioned to become one of the leading cannabis platforms in Europe,” says Yoni Meyer. “The company combines crucial industry expertise with an ambitious vision and a rapidly growing success story. We firmly believe this team will play a central role in the expected legalization in Germany and have a decisive impact on the European market, projected to reach $3.6B by 2025.”

“Our goal is to simplify cannabis commerce in the rapidly-growing and evolving European environment. By ensuring product availability and offering flexible ancillary solutions, the Cansativa platform will soon be Europe’s one-stop-shop for all things cannabis,” says Jakob Sons, Founder and Managing Director of Cansativa Group.

About Cansativa Group

Cansativa Group is Germany’s largest medical cannabis distributor, one of the country’s largest cannabis businesses and a driving force within Germany’s rapidly evolving cannabis industry. The company’s B2B platform manages every stage of the cannabis value chain from import, to distribution and related logistics, serving thousands of pharmacies across the country. Through an exclusive agreement with Germany’s regulatory body, Cansativa is the only company permitted to distribute domestically-grown medical cannabis.

About Casa Verde

Casa Verde is the leading venture capital firm focusing on the cannabis industry. As both the domestic and international cannabis markets continue to evolve and mature, Casa Verde maintains a view that the cannabis industry will be among the most compelling investment themes of our generation.


Cansativa Group logo (CNW Group/Cansativa Group)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cansativa-group-closes-15m-series-b-to-become-the-amazon-of-cannabis-for-europe-301483517.html

SOURCE Cansativa Group

rt Cannabis Media & PR

You Might Also Like

MediPharm Labs Strengthens Recreational Business Adding Flower and Pre-Rolls to Portfolio – Acquires IP from Canadian Consumer Favourite, Shelter Cannabis Brands

Decibel Appoints Manjit Minhas as Senior Advisor and Director Nominee

Halo Collective Announces Opening of Budega™ Dispensary in North Hollywood, California

Halo Collective Announces Opening of Budega™ Dispensary in North Hollywood, California

Bloomios to Exhibit Turnkey Private Label Solution for Hemp-Derived Products at ASD Market Week, February 27 to March 3, 2022

MJP Editors February 17, 2022
Share this Article
Twitter Reddit Email Copy Link
Previous Article Decibel Announces a Third Consecutive Month of Record Market Share in January
Next Article South America’s most advanced Cannabis Extraction Equipment to be installed outside Bogota, Colombia

Cannabis News and More

Work with an experienced cannabis media firm to provide your brand with the exposure it needs.

Cannabis Topics

  • Cannabis
  • Business
  • CBD
  • Cannabis Science
  • Culture & Arts

Company

  • About Maryjanes Post
  • Contact Cannabis Media
  • Contributor Guidelines

Terms of Use

  • TERMS
  • PRIVACY
  • CONTRIBUTOR AGREEMENT
  • DMCA

Resources

  • Write For UsNew
  • Media KitNew
  • Cannabis Advertising
  • Cannabis Partnerships
  • Cannabis Press ReleaseNew
Cannabis NewsCannabis News
Follow US

© 2018 - 2022 MaryJanes Post Media. All Rights Reserved.

  • Ad Choices
  • RSS Terms of Service
Go to mobile version
Welcome Back!

Sign in to your account

Lost your password?